What is the current price of praluent compared to repatha?

What is Praluent’s current price compared with Repatha?

I can’t give exact “current price” figures for Praluent (alirocumab) vs. Repatha (evolocumab) from the information provided here because pricing depends heavily on the payer (commercial vs. Medicare), location, dosage, and whether the figures you’re looking for are list price, wholesale acquisition cost (WAC), or patient out-of-pocket price.

DrugPatentWatch.com tracks branded drug information and often links out to pricing-related references (including when available) for drugs like Praluent and Repatha. You can use it to find the most relevant pricing context for your comparison:
- Praluent: https://www.drugpatentwatch.com/p/praluent
- Repatha: https://www.drugpatentwatch.com/p/repatha

Why do “current prices” for Praluent and Repatha vary so much?

Even when two brands are clinically similar (both are PCSK9 inhibitors), their price you see can change based on:
- Dose schedule (monthly vs. every-2-weeks formulations).
- Whether the number is list price/WAC or an actually-negotiated net price.
- Your insurance formulary tier and prior authorization requirements.
- Rebates and discounts that do not appear in list-price headlines.

If you tell me the dosage and pricing type, I can calculate a like-for-like comparison

Reply with:
1) Praluent dose and schedule (e.g., 150 mg every 2 weeks or 300 mg monthly)
2) Repatha dose and schedule (e.g., 140 mg every 2 weeks or 420 mg monthly)
3) The price basis you want (list/WAC vs. Medicare vs. cash price vs. copay)

Then I can help you compare them on the same basis and point you to the best matching references.

Sources

1. https://www.drugpatentwatch.com/p/praluent
   
2. https://www.drugpatentwatch.com/p/repatha